1-(2,2,2-Trifluoroethyl)piperazine hydrochloride, 95.0%, 100mg

5-(Piperidin-1-yl)nicotinic acid, 95.0%, 250mg

Fmoc-(R)-3-Amino-3-(3-chlorophenyl)-propionic acid, 97%, 250mg

4-Bromo-2-(methylthio)pyrimidine, 95.0%, 5g

4-Fluoro-4'-(trifluoromethyl)-[1,1'-biphenyl]-3-carboxylic acid, 95.0%, 1g

2,6-Dibromoanthracene, 95.0%, 100mg

3-FLUOROCYCLOPENTAN-1-AMINE HYDROCHLORIDE, 95%, 250mg

n-[(2,4-dimethoxyphenyl)methyl]-3-iodo-1h-pyrazolo[4,3-c]pyridin-4-amine, 98%, 10g

GC capillary column ROTI®Cap-5, 25 m, 0.25 mm, 0.50 µm, 1 Piece(s)

6-(tert-Butoxycarbonyl)-6-azaspiro[3.5]nonane-2-carboxylic acid, 97%, 1g

2-(Dimethylamino)acetyl chloride hydrochloride, 95.0%, 1g

METHYL 4-CHLORO-1H-INDAZOLE-7-CARBOXYLATE, 95%, 250mg

2-Fluoro-4-methoxypyridine, 97.0%, 5g